Browse the corpus

Cholestyramine resin is a bile acid sequestrant indicated for treating primary hypercholesterolemia and select cases of bile-acid diarrhea or choleretic enteropathy due to limited ileal disease or resection. The reduction in low-density lipoprotein (LDL) cholesterol achieved with cholestyramine is dose-dependent, making appropriate dosing a key factor in clinical efficacy. This activity presents the pharmacologic profile of cholestyramine, emphasizing indications, mechanism of action, administration strategies, and contraindications. A detailed overview of toxicity, adverse event profiles, and potential drug interactions supports safer prescribing and monitoring practices. Understanding cholestyramine's pharmacodynamics and pharmacokinetics supports individualized treatment planning and enhances therapeutic outcomes for lipid and bile-acid related disorders. This activity highlights the significance of interprofessional collaboration when optimizing cholestyramine therapy, particularly for patients with hyperlipidemia and cholestatic liver disease. Clarifying roles within the healthcare team promotes coordination and precision in care delivery, enables more effective treatment decisions, and improves patient safety and lipid control. Objectives: Evaluate the mechanism of action of cholestyramine. Identify the FDA-approved indications and potential off-label uses for cholestyramine. Assess the potential adverse drug reactions associated with cholestyramine administration. Implement effective collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients who might benefit from cholestyramine therapy. Access free multiple choice questions on this topic.

Signs and Symptoms of Overdose Long-term administration of high doses of cholestyramine can cause toxicity and gastrointestinal obstruction. Management of Overdose First, the location and extent of the obstruction should be identified. Treatment is initiated with IV fluids. Perforation may require surgical intervention.[29] The prognosis is good with proper treatment.

Cholestyramine has been available for over half a century. Most clinicians are not aware of its usefulness as a therapeutic agent for the treatment of both hypercholesterolemia and pruritus. Clinicians providing care to patients with chronic pruritus should be familiar with this agent as it can significantly improve quality of life. Primary caregivers, nurse practitioners, internists, and other clinicians who treat patients with liver failure may find the drug useful for managing pruritus. Nurses can provide patient counseling regarding potential adverse events and dosing and serve as a primary contact point between the patient and the prescribing clinician. Cholestyramine is a relatively safe drug, but patients need to be educated on how to use it for maximal efficiency and prevention of drug interactions. Healthcare professionals who want to use the drug should consult the pharmacist for more practical details such as dosage and duration.[35][36] An interprofessional team approach and cordial communication between physicians, advanced practice providers, pharmacists, and nurses are important to decrease adverse effects and improve outcomes related to cholestyramine therapy.